Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
67%
Ph phase_2
1
33%

Phase Distribution

0

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 3Large-scale testing
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Other(1)

Detailed Status

Completed1
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 21 (33.3%)
Phase 32 (66.7%)

Trials by Status

completed133%
active_not_recruiting133%
unknown133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruitingphase_3

Reducing Vertical Transmission of Hepatitis B in Africa

NCT04704024
completedphase_3

Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention

NCT03870438
unknownphase_2

Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV

NCT03869944

Clinical Trials (3)

Showing 3 of 3 trials
NCT04704024Phase 3

Reducing Vertical Transmission of Hepatitis B in Africa

Active Not Recruiting
NCT03870438Phase 3

Prevention of Mother-to-child Transmission of HIV-1 Using a Responsive Intervention

Completed
NCT03869944Phase 2

Preventing Childhood HIV: Rescue Intervention. ANRS 12388 PREVENIR-PEV

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3